CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination

Yuji Nakamoto, Christian Cohade, Mitsuaki Tatsumi, Dima Hammoud, Richard L. Wahl

Research output: Contribution to journalArticle

Abstract

PURPOSE: To retrospectively evaluate lesion findings at computed tomography (CT) performed as part of a combined positron emission tomography (PET)/CT examination in patients suspected of having metastatic bone lesions-lesions that were detected with fluorine 18 fluorodeoxyglucose (FDG) PET as part of the same examination-and to correlate the CT and FDG PET findings. MATERIALS AND METHODS: This HJPAA-compliant study had institutional review board approval, and the need for patient informed consent was waived. Three hundred fifty-nine consecutive patients (191 male patients, 168 female patients; mean age, 56.9 years; age range, 8-92 years) underwent PET/CT. PET images were first reviewed by nuclear medicine physicians who had no clinical information regarding the presence or absence of bone metastasis by using a five-point grading system (0, a lesion was definitely negative for metastasis; 1, a lesion was probably negative; 2, a lesion was equivocal; 3, a lesion was probably positive; and 4, a lesion was definitely positive). For lesions assigned a grade of 3 or 4 at PET, CT characteristics such as the presence or absence of morphologic changes or accompanying findings (including bone destruction) were assessed by radiologists on the CT images obtained during the same imaging session. RESULTS: One hundred seventy-nine lesions in 55 patients were considered to be probable or definite bone metastases at PET. One hundred thirty-three of these lesions in 33 patients were clinically confirmed to be bone metastases at follow-up and/or histopathologic examination. CT revealed osteolytic changes in 41 (31%) and osteoblastic changes in 21 (16%) of the 133 lesions, but no or nonspecific changes were seen at CT in 49 (37%) and 22 lesions (17%), respectively. Of the 179 lesions suspected at PET, 46 ultimately proved to be nonosseous or false-positive for bone metastasis. Of these 46 lesions, 38 were not located in the bone but in adjacent tissues such as the pleura. CONCLUSION: CT images obtained as part of PET/CT scanning were useful in yielding the precise location of bone lesions and thus helping avoid misdiagnosis of bone metastasis; however, CT revealed morphologic changes in only half of the lesions assigned a grade of 3 or 4 at PET.

Original languageEnglish (US)
Pages (from-to)627-634
Number of pages8
JournalRadiology
Volume237
Issue number2
DOIs
StatePublished - Nov 2005

Fingerprint

Positron-Emission Tomography
Tomography
Neoplasm Metastasis
Bone and Bones
Positron Emission Tomography Computed Tomography
Pleura
Research Ethics Committees
Nuclear Medicine
Fluorodeoxyglucose F18
Diagnostic Errors
Informed Consent
Physicians

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination. / Nakamoto, Yuji; Cohade, Christian; Tatsumi, Mitsuaki; Hammoud, Dima; Wahl, Richard L.

In: Radiology, Vol. 237, No. 2, 11.2005, p. 627-634.

Research output: Contribution to journalArticle

Nakamoto, Y, Cohade, C, Tatsumi, M, Hammoud, D & Wahl, RL 2005, 'CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination', Radiology, vol. 237, no. 2, pp. 627-634. https://doi.org/10.1148/radiol.2372031994
Nakamoto, Yuji ; Cohade, Christian ; Tatsumi, Mitsuaki ; Hammoud, Dima ; Wahl, Richard L. / CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination. In: Radiology. 2005 ; Vol. 237, No. 2. pp. 627-634.
@article{dad26024a83a416fb6184c9af94c3805,
title = "CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination",
abstract = "PURPOSE: To retrospectively evaluate lesion findings at computed tomography (CT) performed as part of a combined positron emission tomography (PET)/CT examination in patients suspected of having metastatic bone lesions-lesions that were detected with fluorine 18 fluorodeoxyglucose (FDG) PET as part of the same examination-and to correlate the CT and FDG PET findings. MATERIALS AND METHODS: This HJPAA-compliant study had institutional review board approval, and the need for patient informed consent was waived. Three hundred fifty-nine consecutive patients (191 male patients, 168 female patients; mean age, 56.9 years; age range, 8-92 years) underwent PET/CT. PET images were first reviewed by nuclear medicine physicians who had no clinical information regarding the presence or absence of bone metastasis by using a five-point grading system (0, a lesion was definitely negative for metastasis; 1, a lesion was probably negative; 2, a lesion was equivocal; 3, a lesion was probably positive; and 4, a lesion was definitely positive). For lesions assigned a grade of 3 or 4 at PET, CT characteristics such as the presence or absence of morphologic changes or accompanying findings (including bone destruction) were assessed by radiologists on the CT images obtained during the same imaging session. RESULTS: One hundred seventy-nine lesions in 55 patients were considered to be probable or definite bone metastases at PET. One hundred thirty-three of these lesions in 33 patients were clinically confirmed to be bone metastases at follow-up and/or histopathologic examination. CT revealed osteolytic changes in 41 (31{\%}) and osteoblastic changes in 21 (16{\%}) of the 133 lesions, but no or nonspecific changes were seen at CT in 49 (37{\%}) and 22 lesions (17{\%}), respectively. Of the 179 lesions suspected at PET, 46 ultimately proved to be nonosseous or false-positive for bone metastasis. Of these 46 lesions, 38 were not located in the bone but in adjacent tissues such as the pleura. CONCLUSION: CT images obtained as part of PET/CT scanning were useful in yielding the precise location of bone lesions and thus helping avoid misdiagnosis of bone metastasis; however, CT revealed morphologic changes in only half of the lesions assigned a grade of 3 or 4 at PET.",
author = "Yuji Nakamoto and Christian Cohade and Mitsuaki Tatsumi and Dima Hammoud and Wahl, {Richard L.}",
year = "2005",
month = "11",
doi = "10.1148/radiol.2372031994",
language = "English (US)",
volume = "237",
pages = "627--634",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "2",

}

TY - JOUR

T1 - CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination

AU - Nakamoto, Yuji

AU - Cohade, Christian

AU - Tatsumi, Mitsuaki

AU - Hammoud, Dima

AU - Wahl, Richard L.

PY - 2005/11

Y1 - 2005/11

N2 - PURPOSE: To retrospectively evaluate lesion findings at computed tomography (CT) performed as part of a combined positron emission tomography (PET)/CT examination in patients suspected of having metastatic bone lesions-lesions that were detected with fluorine 18 fluorodeoxyglucose (FDG) PET as part of the same examination-and to correlate the CT and FDG PET findings. MATERIALS AND METHODS: This HJPAA-compliant study had institutional review board approval, and the need for patient informed consent was waived. Three hundred fifty-nine consecutive patients (191 male patients, 168 female patients; mean age, 56.9 years; age range, 8-92 years) underwent PET/CT. PET images were first reviewed by nuclear medicine physicians who had no clinical information regarding the presence or absence of bone metastasis by using a five-point grading system (0, a lesion was definitely negative for metastasis; 1, a lesion was probably negative; 2, a lesion was equivocal; 3, a lesion was probably positive; and 4, a lesion was definitely positive). For lesions assigned a grade of 3 or 4 at PET, CT characteristics such as the presence or absence of morphologic changes or accompanying findings (including bone destruction) were assessed by radiologists on the CT images obtained during the same imaging session. RESULTS: One hundred seventy-nine lesions in 55 patients were considered to be probable or definite bone metastases at PET. One hundred thirty-three of these lesions in 33 patients were clinically confirmed to be bone metastases at follow-up and/or histopathologic examination. CT revealed osteolytic changes in 41 (31%) and osteoblastic changes in 21 (16%) of the 133 lesions, but no or nonspecific changes were seen at CT in 49 (37%) and 22 lesions (17%), respectively. Of the 179 lesions suspected at PET, 46 ultimately proved to be nonosseous or false-positive for bone metastasis. Of these 46 lesions, 38 were not located in the bone but in adjacent tissues such as the pleura. CONCLUSION: CT images obtained as part of PET/CT scanning were useful in yielding the precise location of bone lesions and thus helping avoid misdiagnosis of bone metastasis; however, CT revealed morphologic changes in only half of the lesions assigned a grade of 3 or 4 at PET.

AB - PURPOSE: To retrospectively evaluate lesion findings at computed tomography (CT) performed as part of a combined positron emission tomography (PET)/CT examination in patients suspected of having metastatic bone lesions-lesions that were detected with fluorine 18 fluorodeoxyglucose (FDG) PET as part of the same examination-and to correlate the CT and FDG PET findings. MATERIALS AND METHODS: This HJPAA-compliant study had institutional review board approval, and the need for patient informed consent was waived. Three hundred fifty-nine consecutive patients (191 male patients, 168 female patients; mean age, 56.9 years; age range, 8-92 years) underwent PET/CT. PET images were first reviewed by nuclear medicine physicians who had no clinical information regarding the presence or absence of bone metastasis by using a five-point grading system (0, a lesion was definitely negative for metastasis; 1, a lesion was probably negative; 2, a lesion was equivocal; 3, a lesion was probably positive; and 4, a lesion was definitely positive). For lesions assigned a grade of 3 or 4 at PET, CT characteristics such as the presence or absence of morphologic changes or accompanying findings (including bone destruction) were assessed by radiologists on the CT images obtained during the same imaging session. RESULTS: One hundred seventy-nine lesions in 55 patients were considered to be probable or definite bone metastases at PET. One hundred thirty-three of these lesions in 33 patients were clinically confirmed to be bone metastases at follow-up and/or histopathologic examination. CT revealed osteolytic changes in 41 (31%) and osteoblastic changes in 21 (16%) of the 133 lesions, but no or nonspecific changes were seen at CT in 49 (37%) and 22 lesions (17%), respectively. Of the 179 lesions suspected at PET, 46 ultimately proved to be nonosseous or false-positive for bone metastasis. Of these 46 lesions, 38 were not located in the bone but in adjacent tissues such as the pleura. CONCLUSION: CT images obtained as part of PET/CT scanning were useful in yielding the precise location of bone lesions and thus helping avoid misdiagnosis of bone metastasis; however, CT revealed morphologic changes in only half of the lesions assigned a grade of 3 or 4 at PET.

UR - http://www.scopus.com/inward/record.url?scp=27144523184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144523184&partnerID=8YFLogxK

U2 - 10.1148/radiol.2372031994

DO - 10.1148/radiol.2372031994

M3 - Article

C2 - 16244271

AN - SCOPUS:27144523184

VL - 237

SP - 627

EP - 634

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 2

ER -